Effect of insulin lispro on glycaemic control in Chinese diabetic patients receiving twice-daily regimens of insulin

Insulin lispro is an insulin analogue that has the advantages of being fast-acting, convenient, and less likely to lead to hypoglycaemic episodes. Previous studies have proven its value in treating both Type 1 and Type 2 diabetes both alone and in combination with different treatment regimens.1,2 However, diabetes is heterogeneous and differs in etiology and clinical characteristics in different ethnic groups. Even with the same insulin treatment, different diets will produce different glycaemic profiles. Diet patterns differ between different ethnic groups. Traditional oriental foods are characterized by a higher proportion of carbohydrates and a lower proportion of fat compared to Caucasian diets. To date, there has been no study on the use of insulin lispro in Chinese diabetic patients. Whether the Chinese dietary pattern will affect the efficacy of insulin lispro treatment remains unknown. Therefore, we conducted this trial to assess the efficacy of insulin lispro treatment in Chinese patients.     

Effect of insulin lispro on glycaemic control in Chinese diabetic patients receiving twice-daily regimens of insulin

Insulin lispro is an insulin analogue that has the advantages of being fast-acting, convenient, and less likely to lead to hypoglycaemic episodes. Previous studies have proven its value in treating both Type 1 and Type 2 diabetes both alone and in combination with different treatment regimens. However, heterogeneous and differs in etiology characteristics in different ethnic groups. diabetes is and clinicalEven with the     

分析美托洛尔联合厄贝沙坦治疗高血压患者的临床效果及对糖脂代谢的影响

目的:评价高血压患者运用美托洛尔治疗的临床价值。方法:从我院选取2018年3月到2019年3月期间高血压患者78例为调查研究对象,均分为对照组和观察组,各39例。对照组患者接受厄贝沙坦,观察组在对照组基础上使用美托洛尔,对比治疗结果。结果:观察组治疗结果优于对照组(P<0.05),差异有统计学意义;用药前两组患者计量指标数据(P>0.05),差异无统计学意义;用药后观察组计量指标数均优于对照组(P<0.05),差异有统计学意义。结论:对高血压患者使用美托洛尔联合厄贝沙坦效果确切明显,提高疗效,降低TG、TC、LDL-C等水平,加速糖脂代谢,适合临床使用。